Related Experiment Video

Updated: Oct 2, 2026

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

[Problems in defining obesity in prepubescent children: consequences for assessing the requirements for medical

S Danielzik1, C Bartel, H Raspe

  • 1Institut für Humanernährung und Lebensmittelkunde, Christian-Albrechts-Universität zu Kiel, Germany. sdanielzik@nutrfoodsc.uni-kiel.de

Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))
|March 21, 2002
PubMed

Insights

Childhood obesity definitions vary, impacting medical rehabilitation needs. A uniform definition is crucial for early intervention and effective obesity prevention strategies in children.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Childhood Obesity Research

Context:

  • Rising global childhood obesity rates present significant public health challenges.
  • Lack of a standardized definition for childhood obesity complicates identification and intervention.
  • Medical rehabilitation needs for obese children are difficult to ascertain due to definitional inconsistencies.

Purpose:

  • To assess the prevalence of overweight and obesity in 5-7 year-old German children using various definitions.
  • To highlight the discrepancies in prevalence estimates based on different diagnostic criteria.
  • To underscore the need for a unified definition to guide medical rehabilitation and preventive measures.

Summary:

  • The Kiel Obesity Prevention Study (KOPS) analyzed 1,643 children aged 5-7 years.
  • Prevalence of overweight ranged from 9% to 21% based on German and international Body Mass Index (BMI) and skinfold thickness standards.
  • Only 3.3-3.5% of children were classified as obese, indicating a potential underestimation with newer BMI criteria.

Impact:

  • A consensus on childhood obesity definition is urgently needed for consistent medical care.
  • Current rehabilitation services target only severely obese children, potentially missing those needing earlier intervention.
  • Enhanced early preventive measures are essential to combat the growing childhood obesity epidemic.
Abstract

More Related Videos

Multidisciplinary Approach to Obesity Management: A Case Report05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...